Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C. Bartsch, Xin Tong, Jaewon Kang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 642
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 386
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Medicine (2022) Vol. 29, Iss. 2, pp. 344-347
Open Access | Times Cited: 381
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 154
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 141
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 128
Neutralization, effector function and immune imprinting of Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
Nature (2023) Vol. 621, Iss. 7979, pp. 592-601
Open Access | Times Cited: 117
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
Zhuoying Huang, Shuangfei Xu, Jiechen Liu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 83
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 80
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 72
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 68
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 46
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 16
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 60
Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults
Janna R. Shapiro, Ioannis Sitaras, Han Sol Park, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_1, pp. S61-S71
Open Access | Times Cited: 43
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
Yannic C. Bartsch, Kerri St. Denis, Paulina Kapłonek, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Open Access | Times Cited: 41
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 37
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Med (2023) Vol. 4, Iss. 3, pp. 191-215.e9
Open Access | Times Cited: 36
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 36
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 31
IgG4 Antibodies Induced by mRNA Vaccines Generate Immune Tolerance to SARS-CoV-2’spike Protein by Suppressing the Immune System
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
(2023)
Open Access | Times Cited: 24
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates
Nanda Kishore Routhu, Samuel D. Stampfer, Lilin Lai, et al.
Science Immunology (2023) Vol. 8, Iss. 88
Open Access | Times Cited: 23
Waning immunity and IgG4 responses following bivalent mRNA boosting
Ninaad Lasrado, Ai‐ris Y. Collier, Jessica Miller, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 15
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals
Jack Mellors, Raman Dhaliwal, Stephanie Longet, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top